KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to $8.0 million.

  • Petmed Express' Accumulated Expenses fell 2673.5% to $8.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $8.0 million, marking a year-over-year decrease of 2673.5%. This contributed to the annual value of $11.7 million for FY2025, which is 6587.82% up from last year.
  • Latest data reveals that Petmed Express reported Accumulated Expenses of $8.0 million as of Q4 2025, which was down 2673.5% from $10.8 million recorded in Q3 2025.
  • Petmed Express' 5-year Accumulated Expenses high stood at $11.7 million for Q1 2025, and its period low was $4.0 million during Q4 2022.
  • Its 5-year average for Accumulated Expenses is $7.0 million, with a median of $6.4 million in 2021.
  • In the last 5 years, Petmed Express' Accumulated Expenses tumbled by 3552.75% in 2024 and then skyrocketed by 10957.51% in 2025.
  • Petmed Express' Accumulated Expenses (Quarter) stood at $4.3 million in 2021, then decreased by 8.11% to $4.0 million in 2022, then soared by 39.66% to $5.6 million in 2023, then surged by 96.54% to $10.9 million in 2024, then fell by 26.74% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q4 2025, $10.8 million for Q3 2025, and $10.9 million during Q2 2025.